The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 28, 2014
Filed:
Nov. 18, 2013
Arnab Kumar Chatterjee, San Diego, CA (US);
Advait Suresh Nagle, San Diego, CA (US);
Prasuna Paraselli, San Diego, CA (US);
Ravinder Reddy Kondreddi, Singapore, SG;
Seh Yong Leong, Singapore, SG;
Pranab Kumar Mishra, San Diego, CA (US);
Robert Joseph Moreau, Emeryville, CA (US);
Jason Thomas Roland, San Diego, CA (US);
Wei Lin Sandra Sim, Singapore, SG;
Oliver Simon, Singapore, SG;
Liying Jocelyn Tan, Singapore, SG;
Bryan K S Yeung, Singapore, SG;
Bin Zou, Singapore, SG;
Venkatataiah Bollu, San Diego, CA (US);
Arnab Kumar Chatterjee, San Diego, CA (US);
Advait Suresh Nagle, San Diego, CA (US);
Prasuna Paraselli, San Diego, CA (US);
Ravinder Reddy Kondreddi, Singapore, SG;
Seh Yong Leong, Singapore, SG;
Pranab Kumar Mishra, San Diego, CA (US);
Robert Joseph Moreau, Emeryville, CA (US);
Jason Thomas Roland, San Diego, CA (US);
Wei Lin Sandra Sim, Singapore, SG;
Oliver Simon, Singapore, SG;
Liying Jocelyn Tan, Singapore, SG;
Bryan K S Yeung, Singapore, SG;
Bin Zou, Singapore, SG;
Venkatataiah Bollu, San Diego, CA (US);
IRM LLC, Hamilton, BM;
Novartis AG, Basel, CH;
Abstract
The present invention provides compounds of formula I: or a pharmaceutically acceptable salt, tautomer, or stereoisomer, thereof, wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by aparasite, such as malaria.